December 3, 2018 / 1:15 PM / 10 days ago

BRIEF-Endocyte - On Nov 30, Waiting Period With Respect To Filing Under Hart-Scott-Rodino Act Expired In Connection With Proposed Merger With Novartis AG

Dec 3 (Reuters) - Endocyte Inc:

* ENDOCYTE SAYS ON NOV 30, 2018, WAITING PERIOD WITH RESPECT TO FILING UNDER HART-SCOTT-RODINO ACT EXPIRED IN CONNECTION WITH PROPOSED MERGER WITH NOVARTIS AG Source text: [bit.ly/2SogDFh] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below